or Try an Advanced Search...

    Technical Analysis for ACRS - Aclaris Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 1.39 2.96% 0.04
    ACRS closed up 2.96 percent on Friday, July 26, 2024, on 43 percent of normal volume.
    Earnings due: Aug 5
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical ACRS trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Overbought Strength 0.72%
    Wide Bands Range Expansion 0.72%
    Overbought Stochastic Strength 0.72%
    180 Bullish Setup Bullish Swing Setup -0.71%
    Gapped Up Strength -0.71%
    Up 3 Days in a Row Strength -0.71%
    1,2,3 Pullback Bullish Bullish Swing Setup 5.30%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.30%
    Inside Day Range Contraction 5.30%
    1,2,3 Pullback Bullish Bullish Swing Setup 6.11%
    Older End-of-Day Signals for ACRS ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 9 hours ago
    Up 2% about 13 hours ago
    10 DMA Support about 13 hours ago
    Up 1% about 13 hours ago
    10 DMA Support 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ACRS Chart by TradingView
    Basic chart:

    Profile

    Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis

    Is ACRS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 23 Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
    Jul 16 Aclaris sells OLUMIANT royalties and milestones to OMERS life sciences
    Jul 16 Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
    Jul 9 Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year?
    Jun 14 $1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
    Jun 6 Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 10 Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates
    May 8 Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
    May 8 Q1 2024 Aclaris Therapeutics Inc Earnings Call
    May 8 Aclaris Therapeutics Inc (ACRS) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
    See more ACRS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.15
    52 Week Low 0.5902
    Average Volume 930,612
    200-Day Moving Average 1.63
    50-Day Moving Average 1.19
    20-Day Moving Average 1.28
    10-Day Moving Average 1.35
    Average True Range 0.07
    RSI (14) 64.54
    ADX 35.45
    +DI 27.22
    -DI 11.43
    Chandelier Exit (Long, 3 ATRs) 1.21
    Chandelier Exit (Short, 3 ATRs) 1.32
    Upper Bollinger Bands 1.45
    Lower Bollinger Band 1.11
    Percent B (%b) 0.81
    BandWidth 27.18
    MACD Line 0.06
    MACD Signal Line 0.05
    MACD Histogram 0.0063
    Fundamentals Value
    Market Cap 98.46 Million
    Num Shares 70.8 Million
    EPS -1.66
    Price-to-Earnings (P/E) Ratio -0.84
    Price-to-Sales 4.00
    Price-to-Book 0.56
    PEG Ratio -0.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.50
    Resistance 3 (R3) 1.49 1.45 1.48
    Resistance 2 (R2) 1.45 1.42 1.45 1.47
    Resistance 1 (R1) 1.42 1.41 1.44 1.43 1.47
    Pivot Point 1.38 1.38 1.39 1.38 1.38
    Support 1 (S1) 1.35 1.35 1.37 1.36 1.31
    Support 2 (S2) 1.31 1.34 1.31 1.31
    Support 3 (S3) 1.28 1.31 1.30
    Support 4 (S4) 1.29